Joshua R Lamstein - Net Worth and Insider Trading
Joshua R Lamstein Net Worth
The estimated net worth of Joshua R Lamstein is at least $10,646 dollars as of 2024-05-22. Joshua R Lamstein is the Director of PAVmed Inc and owns about 5,581 shares of PAVmed Inc (PAVM) stock worth over $10,394. Joshua R Lamstein is also the Chairman, 10% Owner of Scopus BioPharma Inc and owns about 119,997 shares of Scopus BioPharma Inc (SCPS) stock worth over $252. Details can be seen in Joshua R Lamstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua R Lamstein has not made any transactions after 2021-08-27 and currently still holds the listed stock(s).
Transaction Summary of Joshua R Lamstein
Joshua R Lamstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua R Lamstein owns 2 companies in total, including PAVmed Inc (PAVM) , and Scopus BioPharma Inc (SCPS) .
Click here to see the complete history of Joshua R Lamstein’s form 4 insider trades.
Insider Ownership Summary of Joshua R Lamstein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PAVM | PAVmed Inc | 2016-11-18 | director |
SCPS | Scopus BioPharma Inc | 2021-08-27 | director & Chairman |
Joshua R Lamstein Latest Holdings Summary
Joshua R Lamstein currently owns a total of 2 stocks. Among these stocks, Joshua R Lamstein owns 5,581 shares of PAVmed Inc (PAVM) as of November 18, 2016, with a value of $10,394 and a weighting of 97.63%. Joshua R Lamstein also owns 119,997 shares of Scopus BioPharma Inc (SCPS) as of August 27, 2021, with a value of $252 and a weighting of 2.37%.
Latest Holdings of Joshua R Lamstein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PAVM | PAVmed Inc | 2016-11-18 | 5,581 | 1.86 | 10,394 |
SCPS | Scopus BioPharma Inc | 2021-08-27 | 119,997 | 0.00 | 252 |
Holding Weightings of Joshua R Lamstein
Joshua R Lamstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua R Lamstein has made a total of 0 transactions in PAVmed Inc (PAVM) over the past 5 years. The most-recent trade in PAVmed Inc is the acquisition of 13 shares on November 18, 2016, which cost Joshua R Lamstein around $2,190.
According to the SEC Form 4 filings, Joshua R Lamstein has made a total of 6 transactions in Scopus BioPharma Inc (SCPS) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Scopus BioPharma Inc is the acquisition of 400 shares on August 27, 2021, which cost Joshua R Lamstein around $1,980.
Insider Trading History of Joshua R Lamstein
- 1
Joshua R Lamstein Trading Performance
GuruFocus tracks the stock performance after each of Joshua R Lamstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua R Lamstein is -35.01%. GuruFocus also compares Joshua R Lamstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua R Lamstein within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua R Lamstein's insider trading performs compared to the benchmark.
Performance of Joshua R Lamstein
Joshua R Lamstein Ownership Network
Ownership Network List of Joshua R Lamstein
Ownership Network Relation of Joshua R Lamstein
Joshua R Lamstein Owned Company Details
What does PAVmed Inc do?
Who are the key executives at PAVmed Inc?
Joshua R Lamstein is the director of PAVmed Inc. Other key executives at PAVmed Inc include General Counsel Michael Adam Gordon , Chief Operating Officer Shaun O'neil , and director & 10 percent owner & Chairman and CEO Lishan Aklog .
PAVmed Inc (PAVM) Insider Trades Summary
Over the past 18 months, Joshua R Lamstein made no insider transaction in PAVmed Inc (PAVM). Other recent insider transactions involving PAVmed Inc (PAVM) include a net purchase of 250,000 shares made by Michael J Glennon ,
In summary, during the past 3 months, insiders sold 0 shares of PAVmed Inc (PAVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PAVmed Inc (PAVM) were sold and 16,667 shares were bought by its insiders, resulting in a net purchase of 16,667 shares.
PAVmed Inc (PAVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
PAVmed Inc Insider Transactions
Joshua R Lamstein Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua R Lamstein. You might contact Joshua R Lamstein via mailing address: 420 Lexington Avenue, Suite 300, New York Ny 10170.